77 results
424B5
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Prospectus supplement for primary offering
4:02pm
and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We … for a debt or obligation which is owed by us or any of our subsidiary undertakings, to that other person if such director has taken responsibility
8-K
EX-5.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
only applies to those facts and circumstances which exist as at today’s date and we assume no obligation or responsibility to update or supplement
8-K
EX-1.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
of its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent
424B5
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Prospectus supplement for primary offering
4:40pm
for use in connection with this offering. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any … which is owed by us or any of our subsidiary undertakings, to that other person if such director has taken responsibility for some or all
S-3ASR
EX-4.6
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Automatic shelf registration
4:01pm
knowledge and familiarity with the particular subject and who shall have direct responsibility for the administration of this Indenture.
“Rights” has … of, and identity of the exchange rate agent with responsibility for, determining the exchange rate between the currency or currencies, currency unit
S-3ASR
EX-4.4
7kejkeagbk0b offx
11 Sep 24
Automatic shelf registration
4:01pm
S-3ASR
EX-5.1
61rhvrt wlo1p
11 Sep 24
Automatic shelf registration
4:01pm
S-3ASR
r3q3k
11 Sep 24
Automatic shelf registration
4:01pm
DEFA14A
2st75
20 May 24
Additional proxy soliciting materials
8:48pm
PRE 14A
uwd7xw08k
26 Apr 24
Preliminary proxy
4:36pm
424B5
1x86t9xbuwwjkus
24 Apr 24
Prospectus supplement for primary offering
8:53pm
8-K
EX-5.1
qpi9143t9 jqmo
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
8-K
EX-1.1
6ar1g4c2f3b224wjqymu
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
8-K
022e 0a12n1
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
424B5
gvi40ghm 9mq6kqk
23 Apr 24
Prospectus supplement for primary offering
5:16pm
S-8
EX-5.1
ln7fz23juicwg7i05
28 Mar 24
Registration of securities for employees
5:01pm